LOXL2 is a prognosis biomarker and a potential therapeutic target in intrahepatic cholangiocarcinoma
Abstract
no abstract
Journal Articles
HPB
Year : 2016
Laurent Jonchère : Connect in order to contact the contributor
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01310762
Submitted on : Tuesday, May 3, 2016-10:18:48 AM
Last modification on : Friday, March 10, 2023-4:18:23 PM
Cite
D. Bergeat, A. Fautrel, Bruno Turlin, A. Merdrignac, M. Rayar, et al.. LOXL2 is a prognosis biomarker and a potential therapeutic target in intrahepatic cholangiocarcinoma. HPB, 2016, Abstracts of the 11th International Congress of the European-African Hepato-Pancreato-Biliary Association, 21-24 April 2015, Manchester, UK, 18, Supplement 2, pp.e863. ⟨10.1016/j.hpb.2016.01.490⟩. ⟨hal-01310762⟩
Collections
34
View
0
Download